PharmaCyte Biotech Stock Forecast - Rate Of Daily Change

PMCB Stock  USD 2.20  0.07  3.29%   
PharmaCyte Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast PharmaCyte Biotech stock prices and determine the direction of PharmaCyte Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of PharmaCyte Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns. Although PharmaCyte Biotech's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of PharmaCyte Biotech's systematic risk associated with finding meaningful patterns of PharmaCyte Biotech fundamentals over time.
Check out Historical Fundamental Analysis of PharmaCyte Biotech to cross-verify your projections.
For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.
  
The current year's Receivables Turnover is expected to grow to 53.49, whereas Inventory Turnover is forecasted to decline to 2.42. . As of April 25, 2024, Common Stock Shares Outstanding is expected to decline to about 21.3 M. In addition to that, Net Loss is expected to decline to about (5.1 M).

Open Interest Against 2024-05-17 PharmaCyte Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast PharmaCyte Biotech's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in PharmaCyte Biotech's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for PharmaCyte Biotech stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current PharmaCyte Biotech's open interest, investors have to compare it to PharmaCyte Biotech's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of PharmaCyte Biotech is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in PharmaCyte. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
PharmaCyte Biotech has current Rate Of Daily Change of 1.03.
Most investors in PharmaCyte Biotech cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the PharmaCyte Biotech's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets PharmaCyte Biotech's price structures and extracts relationships that further increase the generated results' accuracy.
Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of PharmaCyte Biotech.
Check PharmaCyte Biotech VolatilityBacktest PharmaCyte BiotechInformation Ratio  

PharmaCyte Biotech Trading Date Momentum

On April 25 2024 PharmaCyte Biotech was traded for  2.20  at the closing time. The top price for the day was 2.20  and the lowest listed price was  2.20 . There was no trading activity during the period 0.0. Lack of trading volume on April 25, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.18% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare PharmaCyte Biotech to competition

Other Forecasting Options for PharmaCyte Biotech

For every potential investor in PharmaCyte, whether a beginner or expert, PharmaCyte Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PharmaCyte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PharmaCyte. Basic forecasting techniques help filter out the noise by identifying PharmaCyte Biotech's price trends.

View PharmaCyte Biotech Related Equities

 Risk & Return  Correlation

PharmaCyte Biotech Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of PharmaCyte Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of PharmaCyte Biotech's current price.

PharmaCyte Biotech Market Strength Events

Market strength indicators help investors to evaluate how PharmaCyte Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaCyte Biotech shares will generate the highest return on investment. By undertsting and applying PharmaCyte Biotech stock market strength indicators, traders can identify PharmaCyte Biotech entry and exit signals to maximize returns.

PharmaCyte Biotech Risk Indicators

The analysis of PharmaCyte Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PharmaCyte Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmacyte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PharmaCyte Biotech using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether PharmaCyte Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PharmaCyte Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pharmacyte Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pharmacyte Biotech Stock:
Check out Historical Fundamental Analysis of PharmaCyte Biotech to cross-verify your projections.
For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.
Note that the PharmaCyte Biotech information on this page should be used as a complementary analysis to other PharmaCyte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for PharmaCyte Stock analysis

When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is PharmaCyte Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. If investors know PharmaCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PharmaCyte Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.48)
Return On Assets
(0.05)
Return On Equity
(0.02)
The market value of PharmaCyte Biotech is measured differently than its book value, which is the value of PharmaCyte that is recorded on the company's balance sheet. Investors also form their own opinion of PharmaCyte Biotech's value that differs from its market value or its book value, called intrinsic value, which is PharmaCyte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PharmaCyte Biotech's market value can be influenced by many factors that don't directly affect PharmaCyte Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PharmaCyte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaCyte Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaCyte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.